Norges Bank Exscientia PLC Transaction History

Norges Bank

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$4.35 - $6.88 $165,643 - $261,983	38,079 New	38,079 $244,000
Q3 2023 Nov 13, 2024	BUY	$4.52 - $8.9 $172,117 - $338,903	38,079 New	38,079 $172,000
Q3 2023 Nov 13, 2023	SELL	$4.52 - $8.9 $172,117 - $338,903	-38,079 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$4.79 - $8.3 $182,398 - $316,055	38,079 New	38,079 $225,000
Q2 2023 Aug 14, 2023	SELL	$4.79 - $8.3 $182,398 - $316,055	-38,079 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$5.3 - $10.93 $201,818 - $416,203	38,079 New	38,079 $201,000
Q4 2022 Feb 14, 2023	BUY	$4.1 - $8.94 $156,123 - $340,426	38,079 New	38,079 $202,000
Q3 2022 Nov 13, 2023	BUY	$7.27 - $12.92 $276,834 - $491,980	38,079 New	38,079 $312,000
Q2 2022 Aug 14, 2023	BUY	$6.92 - $15.97 $263,506 - $608,121	38,079 New	38,079 $414,000
Q1 2022 May 09, 2022	SELL	$11.52 - $22.05 $2.36 Million - $4.53 Million	-205,261 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$17.63 - $27.1 $3.62 Million - $5.56 Million	205,261 New	205,261 $4.06 Million

101

33.5M

500

189K

Ticker EXAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 122,461,000
Market Cap $593M
Description
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.